CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront 

Positive
AI Analysis

Summary

Jazz Pharmaceuticals announced the acquisition of Actio Biosciences for $820 million upfront plus up to $500 million in contingent payments.

Importance:7/10
Sentiment:
0.60
M&AacquisitionJazz PharmaceuticalsActio Biosciences
Related Companies

Read the original article

Published by Pharmaceutical Technology on August 11, 2026 8:49 AM

Read Original